NCT00867750 - SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Hepatocellular Carcinoma

Interventions

DEVICE

Radioembolisation (SIR-Spheres® microspheres)

Yttrium-90 SIR-Spheres microspheres

DRUG

Transarterial Chemoembolisation

TACE with embolising agent Embospheres (150-300 μm or 300-500 μm diameter) with 50 mg of chemotherapeutic agent epirubicin admixed with 5 ml lipiodol.

Trial Locations (2)

D-81377

Universitäts-Klinikum München-Grosshadern, Medizinische Klinik und Poliklinik II, München

E-31008

Clinica Universitaria de Navarra, Pamplona